EPISODE · Mar 13, 2017 · 16 MIN
Boardroom Talk: What is the end game for Science in Sport?
from Investors' Chronicle
The importance of nutrition in sporting success has created a big market for elite sports supplements. But is the market for amateur athletes big enough to support growth at Aim-listed group Science in Sport (SIS)? Megan Boxall talks to the group's chief executive, Stephen Moon.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
The importance of nutrition in sporting success has created a big market for elite sports supplements. But is the market for amateur athletes big enough to support growth at Aim-listed group Science in Sport (SIS)? Megan Boxall talks to the group's chief executive, Stephen Moon.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Boardroom Talk: What is the end game for Science in Sport?
No transcript for this episode yet
Similar Episodes
May 8, 2026 ·52m
May 1, 2026 ·50m
Apr 22, 2026 ·26m
Apr 6, 2026 ·51m
Mar 13, 2026 ·53m
Mar 7, 2026 ·53m